Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Adastra Holdings Ltd C.XTRX

Alternate Symbol(s):  XTXXF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Adastra Holdings Ltd. is a Canada-based company, which is engaged in the supply and manufacturing of ethnobotanical and cannabis products. The Company serves medical markets and is engaged in therapeutic applications. The Company’s Phyto Extractions and Endgame Extracts brands distribute cannabis concentrate products through retailers at approximately 2,000 locations across Canada. As a Health... see more

CSE:XTRX - Post Discussion

Adastra Holdings Ltd > Adastra Holdings Reports First Quarter Results
View:
Post by Betteryear2 on May 30, 2023 10:28pm

Adastra Holdings Reports First Quarter Results

  • Record Q1 2023 gross revenues of $9.5M, increase of 315% from Q1 2022
  • Record Q1 2023 cash provided by operations of $1.5M, compared to $104K in Q1 2022
  • Q1 2023 gross profit of $1.7M, increase of 102% from Q1 2022

LANGLEY, BC / ACCESSWIRE / May 30, 2023 / Adastra Holdings Ltd. (CSE:XTRX) (FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands, with a focus on product innovation and commercialization for adult-use and medical markets, is pleased to report financial results for the three months ended March 31, 2023.

Adastra Holdings Reports First Quarter Results; Demonstrating Record Quarterly Gross Revenues of $9.5M (accesswire.com)

Comment by peppesilver57 on Aug 18, 2023 12:35pm
ADASTRA HOLDINGS REPORTS SECOND QUARTER RESULTS; DEMONSTRATING RECORD QUARTERLY REVENUE OF $10.9M   Record Q2 2023 revenue of $10.9M, an increase of 205% from Q2 2022 Record Q2 2023 income from operations of $235K, compared to a loss of $394K in Q2 2022 Q2 2023 gross profit of $2.6M, compared to $1.1M in Q2 2022, an increase of 135%   LANGLEY, BC / ACCESSWIRE /  ...more  
Adastra Holdings Ltd
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities